Innovax-ND-H5 RSSAuthorisedThis medicine is authorised for use in the European UnionTurkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5MedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on Innovax-ND-H5OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Innovax-ND-H5 Active substance Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5 International non-proprietary name (INN) or common name Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5 Pharmacotherapeutic groupLive viral vaccinesDomestic fowlAuthorisation details EMA product number EMEA/V/C/006362 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Innovax-ND-H5Reference Number: EMA/CVMP/165069/2024 English (EN) (98.19 KB - PDF)First published: 25/04/2024ViewNews on Innovax-ND-H5Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 April 202419/04/2024This page was last updated on 03/06/2024Share this page